What is NPS?
Synthetic chemicals designed to mimic the effects of controlled drugs (e.g., synthetic cathinones, cannabinoids), subject to rapid identification and inclusion in drug control frameworks to address public health risks.
New Psychoactive Substances (NPS)
Synthetic chemicals designed to mimic the effects of controlled drugs (e.g., synthetic cathinones, cannabinoids), subject to rapid identification and inclusion in drug control frameworks to address public health risks.
See current New Psychoactive Substances (NPS) activity, then check whether the developments map to your products, sites, suppliers, markets, and internal owners.
Book a demo
Prefer to self-diagnose first? Get a free exposure assessment
Current activity
Intensifying
400% above the prior 8-week baseline
3-month trend
34 alerts tracked
Updated 26 June 2026, 05:41
Topic context
How to read NPS regulatory activity
Why it matters
NPS developments can change product scope, supplier expectations, market access, reporting duties, and risk ownership. Foresight tracks the signals early so teams can respond before obligations become urgent.
How Foresight monitors it
Foresight monitors official sources, extracts structured regulatory intelligence, and maps alerts to a customer's products, substances, markets, and priorities so teams see the relevant signal with source evidence for review.
Frequently asked questions
Everything you need to know about Foresight's regulatory intelligence platform
Still have questions? Get in touch with our team
Join 3,500+ professionals staying ahead
Subscribe to Foresight Weekly for expert-picked regulatory developments across chemicals, sustainability, product safety, ESG, and HSE.
Free forever. Unsubscribe anytime.
Read by professionals at
